ChitogenX Inc. (CHGX.CN) Research

ChitogenX Inc. is a Canadian biologics firm specializing in orthopaedic and sports medicine. The company is dedicated to the research and development of innovative therapeutic technologies designed to improve the success rates of soft tissue repair in sports medicine surgeries. Its product pipeline features several biomaterial-based treatments, including Ortho-R for rotator cuff repair, Ortho-M for meniscus repair, and Ortho-C for articular cartilage repair. Additionally, they are developing Ortho-V to address osteoarthritis healing and ORTHO-T for tendon regeneration. Established in 2015, the company underwent a name change from Ortho Regenerative Technologies Inc. to ChitogenX Inc. in September 2022. It maintains its headquarters in Kirkland, Canada.

Market snapshot

Symbol
CHGX.CN
Price
$0.01
Day change
0.00%
Market cap
$415.6K
P/E ratio
-0.23x
52-week range
0.005-0.045
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 2 days

Peer companies

  • Albert Labs International Corp. (ABRT.CN)
  • Aquarius Surgical Technologies Inc. (ASTI.CN)
  • Bioasis Technologies Inc. (BTI.V)
  • Biocure Technology Inc. (CURE.CN)
  • Global Hemp Group Inc. (GHG.CN)
  • Jack Nathan Medical Corp. (JNH.V)
  • Nirvana Life Sciences Inc. (NIRV.CN)
  • NanoSphere Health Sciences Inc. (NSHS.CN)

Open ChitogenX Inc. (CHGX.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.